11.03
Precedente Chiudi:
$11.37
Aprire:
$11.52
Volume 24 ore:
426.75K
Relative Volume:
0.73
Capitalizzazione di mercato:
$454.63M
Reddito:
$307.31M
Utile/perdita netta:
$-27.71M
Rapporto P/E:
-16.38
EPS:
-0.6732
Flusso di cassa netto:
$-15.27M
1 W Prestazione:
+9.64%
1M Prestazione:
+8.35%
6M Prestazione:
+24.77%
1 anno Prestazione:
+5.50%
Angiodynamic Inc Stock (ANGO) Company Profile
Nome
Angiodynamic Inc
Settore
Industria
Telefono
(518) 798-1215
Indirizzo
14 PLAZA DRIVE, LATHAM
Compare ANGO vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ANGO
Angiodynamic Inc
|
11.03 | 468.64M | 307.31M | -27.71M | -15.27M | -0.6732 |
|
ISRG
Intuitive Surgical Inc
|
478.60 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
177.81 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.55 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.59 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
245.73 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-16 | Iniziato | Lake Street | Buy |
| 2024-04-05 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-09-25 | Iniziato | H.C. Wainwright | Buy |
| 2023-04-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-10-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-08-20 | Iniziato | Oppenheimer | Perform |
| 2020-11-25 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2020-04-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-01 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2018-04-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-01-05 | Downgrade | Craig Hallum | Buy → Hold |
| 2017-04-07 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-03-30 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-02-08 | Iniziato | Barclays | Equal Weight |
| 2016-11-04 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-04-08 | Ripresa | Piper Jaffray | Neutral |
| 2016-01-08 | Reiterato | Canaccord Genuity | Buy |
| 2015-11-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-07-24 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2014-06-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2012-10-09 | Reiterato | Canaccord Genuity | Hold |
| 2012-06-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2011-07-15 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2011-07-15 | Aggiornamento | Stifel Nicolaus | Hold → Buy |
| 2011-06-14 | Downgrade | Wedbush | Neutral → Underperform |
| 2010-09-08 | Reiterato | Wedbush | Neutral |
Mostra tutto
Angiodynamic Inc Borsa (ANGO) Ultime notizie
Essex Investment Management Co. LLC Increases Holdings in AngioDynamics, Inc. $ANGO - MarketBeat
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect? - Finviz
Here's Why You Should Add Masimo Stock to Your Portfolio Now - Finviz
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now - Finviz
Reasons to Add AngioDynamics Stock to Your Portfolio for Now - Finviz
Is AngioDynamics Inc. stock a smart retirement pick2025 Trading Recap & Weekly Stock Performance Updates - Mfd.ru
AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring An 81.88% Potential Upside - DirectorsTalk Interviews
Fed Watch: What is XPO Inc.’s market positionWall Street Watch & Smart Allocation Stock Tips - baoquankhu1.vn
Portfolio Update: Will AngioDynamics Inc stock benefit from M AEarnings Overview Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
RSI Check: Why is AngioDynamics Inc stock going down2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
Treasury Yields: Will AngioDynamics Inc stock recover after earnings2025 Major Catalysts & Proven Capital Preservation Methods - baoquankhu1.vn
AngioDynamics Inc Presents at J.P. Morgan Healthcare Conference - TradingView
AngioDynamics to lay off 54 workers in Glens Falls, Queensbury - timesunion.com
3 MedTech Stocks Benefiting From Favorable Product Mix Shifts - Finviz
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO) - Finviz
Assessing AngioDynamics (ANGO) Valuation After Raised Guidance And Med Tech Momentum - simplywall.st
How AngioDynamics Inc. stock reacts to oil pricesJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Earnings Beat: Why AngioDynamics Inc. stock is seen as undervaluedWeekly Investment Report & Entry Point Confirmation Alerts - Улправда
Is AngioDynamics Inc. stock a defensive play in 2025Portfolio Risk Report & Low Risk Entry Point Tips - Улправда
Why AngioDynamics Inc. stock is seen as undervaluedMarket Growth Summary & Low Risk Profit Maximizing Plans - Улправда
Why AngioDynamics Inc. (UG2) stock remains top rated2025 Dividend Review & High Win Rate Trade Tips - Улправда
Will AngioDynamics Inc. stock benefit from commodity prices2025 Short Interest & Accurate Buy Signal Alerts - ulpravda.ru
Why AngioDynamics Inc. stock is recommended by analystsJuly 2025 Selloffs & Smart Allocation Stock Tips - Улправда
Is AngioDynamics' (ANGO) Higher Sales Guidance Enough To Offset CEO Transition Concerns? - Yahoo Finance
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2026 Earnings Call Transcript - Insider Monkey
AngioDynamics Q2 Earnings Call Highlights - Defense World
ANGIODYNAMICS INC SEC 10-Q Report - TradingView — Track All Markets
AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Revises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Earnings Summary: AngioDynamics (ANGO) Q2 FY26 sales increase 8.8% - AlphaStreet
Why hedge funds are buying AngioDynamics Inc. stock2026 world cup usa national team third place match young talents pressing system match prediction breakdown - ulpravda.ru
AngioDynamics, Microchip Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Aug Decliners: Will AngioDynamics Inc stock benefit from AI adoptionBear Alert & Accurate Entry/Exit Alerts - moha.gov.vn
AngioDynamics Vortex Failure Led to Port Catheter Removal, Lawsuit - AboutLawsuits.com
AngioDynamics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Sahm
AngioDynamics (ANGO) to Release Earnings on Tuesday - Defense World
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha
Trend Recap: Why AngioDynamics Inc UG2 stock remains top ratedTrade Exit Summary & Low Risk High Reward Trade Ideas - moha.gov.vn
AngioDynamics, Inc. (NASDAQ:ANGO): When Will It Breakeven? - Yahoo Finance
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now - Finviz
Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan
New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan
Why AngioDynamics Inc. stock remains on buy listsWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber
Will AngioDynamics Inc. stock attract more institutional investorsSwing Trade & Growth Focused Stock Pick Reports - Улправда
How rising interest rates impact AngioDynamics Inc. stockTrade Entry Report & Technical Analysis for Trade Confirmation - Улправда
How the Printed Matter Doctrine Sees Through X-Ray Markers - Patently-O
PATENT—Fed. Cir.: Bard’s vascular access port patents properly invalidated despite prior jury verdict - VitalLaw.com
Armistice Capital LLC Sells 566,185 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
Panagora Asset Management Inc. Sells 138,518 Shares of AngioDynamics, Inc. $ANGO - MarketBeat
The Market Doesn't Like What It Sees From AngioDynamics, Inc.'s (NASDAQ:ANGO) Revenues Yet - simplywall.st
Angiodynamic Inc Azioni (ANGO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):